MCS110   Click here for help

GtoPdb Ligand ID: 9110

Immunopharmacology Ligand
Compound class: Antibody
Comment: MCS110 is a myeloid cell targeting agent, specifically an IgG1 kappa monoclonal antibody against the ligand CSF-1 (a.k.a. M-CSF). It is being investigated for its immuno-oncology potential. This is one of the antibody constructs claimed in patent WO2007016240 [1].
References
1. Kavanaugh WM. (2007)
Use of antibody to m-csf.
Patent number: WO2007016240 A2. Assignee: Novartis Ag, Xoma Technology Ltd.. Priority date: 28/07/2005. Publication date: 08/02/2007.